These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18824608)

  • 41. The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects.
    Johnson M; Jewell RC; Peppercorn A; Gould E; Xu J; Lou Y; Davies M; Baldwin S; Tenorio AR; Burke M; Jeffrey J; Johns BA
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00408. PubMed ID: 29930812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial.
    Kakuda TN; Leopold L; Nijs S; Vandevoorde A; Crauwels HM; Bertelsen KM; Stevens M; Witek J; van Delft Y; Tomaka F; Hoetelmans RM
    J Clin Pharmacol; 2014 May; 54(5):563-73. PubMed ID: 25975423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.
    Hughes W; McDowell JA; Shenep J; Flynn P; Kline MW; Yogev R; Symonds W; Lou Y; Hetherington S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):609-15. PubMed ID: 10049275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients.
    Cato A; Qian J; Hsu A; Levy B; Leonard J; Granneman R
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1788-93. PubMed ID: 9661022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute bioavailability and disposition of (-) and (+) 2'-deoxy- 3'-oxa-4'-thiocytidine (dOTC) following single intravenous and oral doses of racemic dOTC in humans.
    Smith PF; Forrest A; Ballow CH; Martin DE; Proulx L
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1609-15. PubMed ID: 10817717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys.
    Balani SK; Kauffman LR; deLuna FA; Lin JH
    Drug Metab Dispos; 1999 Jan; 27(1):41-5. PubMed ID: 9884307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of single oral doses of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in healthy volunteers.
    Holdich T; Shiveley L; Sawyer J
    Clin Drug Investig; 2006; 26(5):279-86. PubMed ID: 17163261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children.
    Wang LH; Wiznia AA; Rathore MH; Chittick GE; Bakshi SS; Emmanuel PJ; Flynn PM
    Antimicrob Agents Chemother; 2004 Jan; 48(1):183-91. PubMed ID: 14693538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteers.
    Moore KH; Cass LM; Dallow N; Hardman TC; Jones A; Boyce M; Prince WT
    J Clin Pharmacol; 2001 Oct; 41(10):1098-105. PubMed ID: 11583478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
    Sanchez RI; Yee KL; Fan L; Cislak D; Martell M; Jordan HR; Iwamoto M; Khalilieh S
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):107-114. PubMed ID: 30973682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the pharmacokinetic interaction between ritonavir and CMDCK, a new non-nucleoside reverse transcriptase inhibitor.
    Zhuang XM; Shen GL; Yuan M; Li H
    Drug Res (Stuttg); 2013 May; 63(5):237-42. PubMed ID: 23539429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers.
    Lamson MJ; Sabo JP; MacGregor TR; Pav JW; Rowland L; Hawi A; Cappola M; Robinson P
    Biopharm Drug Dispos; 1999 Sep; 20(6):285-91. PubMed ID: 10701699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers.
    Schöller-Gyüre M; van den Brink W; Kakuda TN; Woodfall B; De Smedt G; Vanaken H; Stevens T; Peeters M; Vandermeulen K; Hoetelmans RM
    J Clin Pharmacol; 2008 Mar; 48(3):322-9. PubMed ID: 18195053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males.
    Smith PF; Forrest A; Ballow CH; Martin DE; Proulx L
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2816-23. PubMed ID: 10991865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients.
    Borin MT; Cox SR; Herman BD; Carel BJ; Anderson RD; Freimuth WW
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1892-7. PubMed ID: 9303380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.
    Ankrom W; Jackson Rudd D; Schaeffer A; Panebianco D; Friedman EJ; Tomek C; Stoch SA; Iwamoto M
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0093521. PubMed ID: 34516246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and pharmacokinetics of 5-chloro-2',3'-dideoxy-3'-fluorouridine (935U83) following oral administration of escalating single doses in human immunodeficiency virus-infected adults.
    Riddler SA; Wang LH; Bartlett JA; Savina PM; Packard MV; McMahon DK; Blum MR; Dunn JA; Elkins MM; Mellors JW
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2842-7. PubMed ID: 9124852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial.
    Matthews RP; Patel M; Barrett SE; Haspeslagh L; Reynders T; Zhang S; Rottey S; Goodey A; Vargo RC; Grobler JA; Stoch SA; Iwamoto M
    Nat Med; 2021 Oct; 27(10):1712-1717. PubMed ID: 34608329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The bioavailability of the novel nonnucleoside reverse transcriptase inhibitor GW420867X is unaffected by food in healthy male volunteers.
    Cass LM; Moore KH; Dallow NS; Jones AE; Sisson JR; Prince WT
    J Clin Pharmacol; 2001 May; 41(5):528-35. PubMed ID: 11361049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a single dose of ritonavir on the pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered in healthy volunteers.
    Colucci P; Pottage JC; Robison H; Turgeon J; Ducharme MP
    Antimicrob Agents Chemother; 2009 Feb; 53(2):646-50. PubMed ID: 19015353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.